Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

BioXcel Therapeutics, Inc. (BTAI)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
15.00-0.36 (-2.34%)
At close: 04:00PM EDT
15.59 +0.59 (+3.93%)
After hours: 05:08PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close15.36
Open15.76
Bid14.81 x 900
Ask15.58 x 1000
Day's Range14.61 - 15.79
52 Week Range8.80 - 36.49
Volume516,123
Avg. Volume533,106
Market Cap419.777M
Beta (5Y Monthly)1.18
PE Ratio (TTM)N/A
EPS (TTM)-4.11
Earnings DateNov 08, 2022 - Nov 14, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est50.64
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for BTAI

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • BioXcel Therapeutics, Inc.
    Analyst Report: Merck & Co IncMerck & Co. is a worldwide pharmaceutical company. Its major drugs include treatments in oncology and diabetes. The company also has a leading vaccine business and an animal health division. MRK shares are included in the S&P 500.
    Rating
    Fair Value
    Economic Moat
    14 hours agoArgus Research
View more
Advertisement
Advertisement